Expression of hyaluronan in human tumor progression. - Wikidata - awgldk - TriplyDB

Expression of hyaluronan in human tumor progression.

Expression of hyaluronan in human tumor progression.

http://www.wikidata.org/entity/Q25256742

about

Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1)Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy The detection of glycosaminoglycans in pancreatic islets and lymphoid tissues.Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Improved biochemical strategies for targeted delivery of taxoids Role of hyaluronan in glioma invasion.Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma.Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate.Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer.Hypotheses on the evolution of hyaluronan: a highly ironic acid.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.Detection of a specific pattern of hyaluronan oligosaccharides and their binding proteins in human ovarian tumour.Development and validation of H11B2C2 monoclonal antibody-reactive hyaluronic acid binding protein: overexpression of HABP during human tumor progression.Applications of capillary electrophoresis electrospray ionization mass spectrometry in glycosaminoglycan analysis.4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines.Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib.4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.

P2860

Q24294210-0224D93A-A359-4F68-A09C-B43D73FFDB31 Q26784055-6D3EEA74-3659-49C4-97A8-7CD4A5E755F5 Q34522475-A7614E47-9C5F-467B-97B0-CC18E8BBFCA5 Q34874835-6A2A8DB0-08E4-4552-AAE6-82BD610F488D Q36642502-F1B5214D-FA96-4333-AC3C-110863F9FADC Q37079980-1EA8AE1D-5E39-4018-A920-34B9F41402D9 Q37142553-2ED1FA42-4B1A-44E5-8136-A15D34BDD311 Q37563823-BD90F06D-A68F-4B8E-805F-5FBD52B28606 Q37657329-C6FFF210-F9E7-49A2-90E2-422BECBA7EAB Q38073724-DAE920C4-BB15-4436-903D-6A79F8D7B5A5 Q38260975-F00F0B4E-1268-4502-B6D6-AF33F05D9C21 Q38293112-D171EBCA-4EFA-43FF-AFCA-E6B55CFE7746 Q38320495-7CA95857-66D1-434A-B8D9-07E88D616E87 Q38678456-A40235B5-BB0B-470F-8FC3-F7B24DE2E695 Q38741990-CD3C85F7-3459-4B96-A554-CB21C585BA0A Q38818540-EB225915-5ECB-4D87-9CDD-FAA770E32840 Q38886114-C3B6B646-F2BC-4ECA-8BCD-DA59C02965E2 Q38944271-56D3D618-6646-437A-834F-C7B6AA2994CA Q39450694-39E18546-3DD9-49AA-8EF3-5EF141FED7A7 Q41898534-EA29687B-2958-440F-A8E1-71E1F0600563 Q42347025-2EE797F2-F9E3-4D57-BD86-4D1712B7A42A Q45870608-F86566BA-4B03-48C7-8E52-7CF9871693B7

P2860

Expression of hyaluronan in human tumor progression.

http://www.wikidata.org/entity/Q25256742

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Expression of hyaluronan in human tumor progression

@nl

Expression of hyaluronan in human tumor progression.

@ast

Expression of hyaluronan in human tumor progression.

@en

type

label

Expression of hyaluronan in human tumor progression

@nl

Expression of hyaluronan in human tumor progression.

@ast

Expression of hyaluronan in human tumor progression.

@en

prefLabel

Expression of hyaluronan in human tumor progression

@nl

Expression of hyaluronan in human tumor progression.

@ast

Expression of hyaluronan in human tumor progression.

@en

P1433

Q25256742-0694EAF7-D7CF-410D-A945-5B15724AD22E

P1476

Q25256742-CCFB461F-E455-43E3-A645-41C3796E7BA1

P2093

Q25256742-0F153825-1F0E-46B2-B3E4-4AD633FACD17

Q25256742-71B509E5-3A24-4215-9150-11E4141654B3

Q25256742-898D3E17-E6E5-4AFE-867C-1DFBD54C19AC

Q25256742-99F97AF4-6EB6-4C18-A956-AD953FC9B03C

Q25256742-A85EDD85-4735-41D8-A2E0-E6491BAF2137

Q25256742-A966C06E-5CF4-44C8-B438-DCE25221C4CB

Q25256742-C36AC485-3F30-4211-B9D8-174772D7416E

Q25256742-D0DC4795-5F36-4E37-98B3-64E648F1E558

Q25256742-E9B5624C-1D20-4977-B3D0-73CDDCA46798

P2860

Q25256742-0103AB36-9EC9-4AFB-ABE7-BEFD1E6CD204

Q25256742-0CB732A2-DD04-47CA-AF5C-6D6DDF2D39E4

Q25256742-0D9B0EA9-E523-44EB-BA02-B355EE1E61A4

Q25256742-1BFB365E-57A5-4828-8BF8-B90A577021FC

Q25256742-211242C1-26D0-41E8-B1EF-D38013FAD4F1

Q25256742-2D624858-FF30-450C-BE90-2EDF61AB5727

Q25256742-2E187AED-CB0E-4DDC-B192-2B511907D924

Q25256742-2FE1E752-4FCE-4F2F-B8B1-634A229A9ADA

Q25256742-351F5D88-6741-4A20-82CE-8B621835B69D

Q25256742-40910508-5620-476B-9589-B1FC1815DAFB

P304

Q25256742-43787480-88D8-4B08-BBC6-D49B4EDF822D

P31

Q25256742-159E1C9F-8B4F-42F0-8EEB-F0BC80C747A8

P356

Q25256742-D7D30CCD-C3FA-427C-8279-E449177D92B8

P407

Q25256742-37B8A8DD-68CD-45E1-B53C-04917F7F8039

P433

Q25256742-929DA76C-49AB-4496-8F75-15F0B36A88B3

P478

Q25256742-CCC66A13-4DB3-406C-A859-0177033CEE4D

P577

Q25256742-FD1C006B-4605-4146-B657-B8E8E770E2B9

P5875

Q25256742-CC8622A2-E864-4359-BE07-C041B8AB2712

P698

Q25256742-324F1BF4-08C8-4FFE-95E5-A545C8C329B1

P932

Q25256742-67A17CA2-A13A-4BB7-85DF-48FF021FE3D7

P356

P1433

Journal of Carcinogenesis

P1476

Expression of hyaluronan in human tumor progression.

@en

P2093

Bryan Toole

http://www.w3.org/2001/XMLSchema#string

Hitesh N Appaiah

http://www.w3.org/2001/XMLSchema#string

K N Thimmaiah

http://www.w3.org/2001/XMLSchema#string

KarunaKumar Mortha

http://www.w3.org/2001/XMLSchema#string

Manjunath Siddaiah

http://www.w3.org/2001/XMLSchema#string

Rajeev K Boregowda

http://www.w3.org/2001/XMLSchema#string

Shib d Banerjee

http://www.w3.org/2001/XMLSchema#string

Sunil B Kumarswamy

http://www.w3.org/2001/XMLSchema#string

Sunila Sunila

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2

Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells

Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis

Tumor cell interactions with the extracellular matrix during invasion and metastasis

Molecular characterization of a novel intracellular hyaluronan-binding protein

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

Matrix metalloproteinases and metastasis.

Hyaluronate and invasiveness of the rabbit V2 carcinoma

The structure and function of hyaluronan: An overview.

Hyaluronan and homeostasis: a balancing act.

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-3163-5-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7371202

http://www.w3.org/2001/XMLSchema#string

P698

16401353

http://www.w3.org/2001/XMLSchema#string

P932

1360664

http://www.w3.org/2001/XMLSchema#string